Replies to post #244608 on Biotech Values

[DewDiligence]

AZN acquires CINC for $26/sh cash +CVR:

https://www.globenewswire.com/news-release/2023/01/09/2584810/0/en/CinCor-Pharma-to-be-Acquired-by-AstraZeneca.html

The buyout price (excluding the CVR) is a 121% premium to Friday’s closing price. The nominal deal value (sans CVR) is $1.3B.

CINC IPOd one year ago at $16.00 (#msg-167415784).